SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹115 Cr | ₹100 Cr | ₹99 Cr | ₹72 Cr | ₹6,343,119 Cr |
What is the latest Total Expenditure of SAKAR HEALTHCARE ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹115 Cr |
| Mar2024 | ₹100 Cr |
| Mar2023 | ₹99 Cr |
| Mar2022 | ₹72 Cr |
| Mar2021 | ₹6,343,119 Cr |
How is Total Expenditure of SAKAR HEALTHCARE Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹115 Cr | 14.86 | |
| Mar2024 | ₹100 Cr | 1.22 | |
| Mar2023 | ₹99 Cr | 37.10 | |
| Mar2022 | ₹72 Cr | -100.00 | |
| Mar2021 | ₹6,343,119 Cr | - | |
Compare Total Expenditure of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,190.9 Cr | 2.3% | 5.2% | 117.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 2.3% |
5.2% |
117.1% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses